According to research published in the Molecular Oncology journal, Vitamin D supplementation in those over the age of 50 in Germany was associated with a ‘significant reduction’ in cancer mortality, with it estimated to prevent almost 30,000 cancer deaths per year.

From a monetary perspective, the approximate costs of such a widescale program would be €900 million, but with associated healthcare savings of €1.154 billion, it would produce estimated net savings of €254 million.